Last $29.33 USD
Change Today -0.39 / -1.31%
Volume 1.4M
NPSP On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - nps pharmaceuticals inc (NPSP)

Name (Connections)Board RelationshipsTitleKey Developments
Peter Tombros M.S., M.B.A 36 RelationshipsChairman, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation CommitteeNPS Pharmaceuticals Inc. announced delayed 10-Q filing
05/10/04
Rachel Selisker CPA 13 RelationshipsDirector and Chairman of Audit CommitteeNPS Pharmaceuticals, Inc. announced delayed 10-Q filing
05/12/08
James Groninger M.B.A 13 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit Committee 
Georges Gemayel Ph.D. 45 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 

Compensation Committee* - nps pharmaceuticals inc (NPSP)

Name (Connections)Board RelationshipsTitle
Colin Broom M.D. 7 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Georges Gemayel Ph.D. 45 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Pedro Granadillo B.S. 41 RelationshipsDirector and Chairman of Compensation Committee
Peter Tombros M.S., M.B.A 36 RelationshipsChairman, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
NPSP Compensation vs. Industry
600.0K
372.7K
Chief Executive Officer
413.7K
273.5K
Chief Financial Officer
Share price activity for NPS PHARMACEUTICALS INC (NPSP)
52 Week Price Performance
NPSP
Industry Average

Nominating Committee* - nps pharmaceuticals inc (NPSP)

Name (Connections)Board RelationshipsTitleKey Developments
Peter Tombros M.S., M.B.A 36 RelationshipsChairman, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation CommitteeNPS Pharmaceuticals Announces Executive Appointments
03/25/14
Michael Bonney B.A. 27 RelationshipsDirector and Chairman of Nominating & Corporate Governance CommitteeNPS Pharmaceuticals, Inc. Announces Executive Changes
03/5/14
James Groninger M.B.A 13 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit CommitteeNPS Pharmaceuticals, Inc. Announces Retirement of Edward Stratemeier as Senior Vice President, Legal Affairs, General Counsel and Corporate Secretary
12/19/13
Colin Broom M.D. 7 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance CommitteeNPS Pharmaceuticals, Inc. Appoints Georges Gemayel to its Board of Directors
02/29/12

Corporate Governance Committee* - nps pharmaceuticals inc (NPSP)

Name (Connections)Board RelationshipsTitle
Michael Bonney B.A. 27 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Colin Broom M.D. 7 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
James Groninger M.B.A 13 RelationshipsDirector and Chairman of Compensation Committee
Peter Tombros M.S., M.B.A 36 RelationshipsChairman, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
NPSP and Competitor
Insiders vs. External
Board
13%
87%
NPS Pharmaceuticals, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NPSP:US $29.33 USD -0.39

NPSP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NPSP.
View Industry Companies
 

Industry Analysis

NPSP

Industry Average

Valuation NPSP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.7x
Price/Book 29.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 16.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NPS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.